HoFH: New insights in prevalence and therapy

3' education - Oct. 26, 2014 - Snapshot 2014 - dr Kees Hovingh

Dr. Kees Hovingh, Amsterdam, NL, shares some new insights in the prevalence of Homozygous and Heterozygous Familial Hypercholesterolemia and novel therapeutic options to lower LDL-c in this patient population

The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.